Denise Dignam - 03 Mar 2025 Form 4 Insider Report for Chemours Co (CC)

Role
President & CEO, Director
Signature
/s/ Kristine Wellman, Attorney-in-Fact
Issuer symbol
CC
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 20:48:14 UTC
Previous filing
04 Mar 2025
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Award $0 +106,421 +150% $0.000000 177,211 03 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +353,717 $0.000000 353,717 03 Mar 2025 Common Stock 353,717 $13.86 Direct F3
transaction CC Stock Option (Right to Buy) Award $0 +367,866 $0.000000 367,866 03 Mar 2025 Common Stock 367,866 $15.25 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026.
F2 Includes directly owned shares, RSUs and dividend equivalent units.
F3 These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.
F4 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.